Risk of malignancy in small pancreatic cysts decreases over time

Area of Science:

• Gastroenterology
• Oncology
• Surgical Oncology

Background:

• Pancreatic cysts under 15 mm without worrisome features have minimal initial malignancy risk.
• Optimal surveillance duration for these small pancreatic cysts remains debated.
• Understanding predictors of malignant transformation is crucial for patient management.

Purpose of the Study:

• To evaluate predictors of malignancy in small pancreatic cysts (<15 mm).
• To identify a safe time point to discontinue surveillance for these cysts.
• To assess the long-term risk of malignant transformation.

Main Methods:

• A bi-centric study analyzed prospectively collected data from patients with small pancreatic cysts.
• Kaplan-Meier method and parametric survival models assessed malignant transformation risk.
• Cox regression identified predictors of malignancy, including cyst size changes and development of worrisome features.

Main Results:

• Of 806 patients, 1.7% developed malignancy over a median follow-up of 58 months.
• Cyst size increase (≥2.5 mm/year) was the strongest predictor (HR=29.54).
• Development of worrisome features also predicted malignancy (HR=9.17); risk decreased significantly after 3-5 years of surveillance.

Conclusions:

• Small pancreatic cysts (<15 mm) have a very low risk of malignant transformation.
• The risk of malignancy decreases over time with continued surveillance.
• Cyst size increase is the primary indicator for malignancy risk in these patients.